Saturday, July 11, 2026

Drug profile · INN

fluorescein sodium

fluorescein sodium (FUNDUSCEIN-25) is a disclosing agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fluorescein sodium
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

fluorescein sodium (FUNDUSCEIN-25) is a disclosing agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN fluorescein sodium
Brand FUNDUSCEIN-25
Mechanism Disclosing agent
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Disclosing agent

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is fluorescein sodium?

fluorescein sodium (FUNDUSCEIN-25) is a disclosing agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for fluorescein sodium?

FUNDUSCEIN-25 is a marketed brand name for fluorescein sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluorescein sodium?

fluorescein sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.